(AFX UK Focus) 2008-05-15 09:14 India's Zydus Cadila gets 4 product approvals from U.S. FDA (Interactive Investor)
MUMBAI (Thomson Financial) - Indian pharmaceuticals company Zydus Cadila said it received four product approvals from the U.S. Food and Drug Administration with a market size of $6.498 billion.

Zydus Cadila gets four US FDA approvals (PharmaBiz)
Zydus Cadila has received four product approvals from US FDA. The group has received approvals to market Pravastatin' sodium tablets USP 10, 20, 40 and 80 mg and tentative approvals for Escitalopram Oxalate' tablets 5,10 and 20 mg, Losartan Potassium and Hydroeblorthiazide tablets 50 mgIl2.5 mg and 100 mgtl5 mg and Anastrazole tablets 1mg.